Sendurai Mani: Team Science in Oncology

Sendurai Mani shared on LinkedIn:

“𝐓𝐞𝐚𝐦 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐢𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲

Cancer is a devastating disease, but with advanced diagnostic methods, we are now able to detect it more accurately. While cancer-related mortality has been steadily decreasing for most cancers, unfortunately, this is not the case for pancreatic cancer, liver cancer, and a few others. Clinicians and Researchers around the world understand the challenges we face in the fight against these types of cancer, and we are all committed to overcoming them together.

I am incredibly thankful to Wafik S. El-Deiry, Howard Safran, Jake Kurtis, Mukesh Jain, and others for recruiting me to The Warren Alpert Medical School of Brown University. Our dedicated team at the Legorreta Cancer Center at Brown University, including exceptional colleagues like Robert W. Sobol Jr., Benedito A. Carneiro, Don S. Dizon, Stephanie Graff, Hina Khan, Alex Raufi, Jerry Azzoli, David Wazer, Shiyoko Cothren, Liang Cheng, Jeremy Warner, Sheldon Holder, Paul DiSilvestro, Michelle R Dawson, Cara Mathews, Attila Seyhan, Neil Sarkar, Rishi R. Lulla, Sean Lawler, Patrycja Dubielecka, Roxanne Wood, Sharon Rounds, Juan Alfonzo, Fairbrother William, John Sedivy, and many others, are tirelessly working to reduce cancer incidence and improve survival rates here in Rhode Island and beyond.

A special thanks to our tireless leader and director, Wafik S. El-Deiry, for his unwavering dedication to bringing our team together to achieve this vital goal.”

Source: Sendurai Mani/LinkedIn

Sendurai Mani is a distinguished Indian-American oncologist and molecular biologist. Currently holding the Dean’s Chair for Translational Oncology at Brown University Warren Alpert Medical School, Dr. Mani also serves as the Associate Director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School.

Prior to his current roles, he held positions as Co-Director of the Metastasis Research Center and the Center for Stem Cell & Developmental Biology, as well as Professor of Translational Molecular Pathology at UT MD Anderson Cancer Center.

Dr. Mani’s research focuses on finding the mechanisms driving cancer metastasis and therapy resistance, particularly in breast cancer. He is renowned for his discovery of cancer stem cells and their pivotal role in tumor progression and treatment resistance.

Dr. Mani is committed to mentoring the next generation of cancer researchers, and guiding graduate students, postdoctoral fellows, and junior faculty members in their scientific pursuits.

He has been honored with numerous awards, including the Susan G. Komen for the Cure Scholar Award and the American Association for Cancer Research (AACR) Scholar-in-Training Award. Through his dedication, Dr. Sendurai Mani continues to lead the way in advancing our understanding of cancer biology and improving treatment strategies.